发明名称 |
USE OF IGF-1 IN THE MODULATION OF TREG CELL ACTIVITY AND THE TREATMENT AND PREVENTION OF AUTOIMMUNE DISORDERS OR DISEASES |
摘要 |
The present invention relates to the use of the Insulin-like growth factor-I (IGF-1) in immune modulation and/or in the treatment or prevention of pathogenic or aberrant immune responses or disorders and/or for use in the treatment or prevention of T-cell mediated disorders or diseases and/or for use in the treatment or prevention of diseases where the immune system contributes to the disease state. |
申请公布号 |
EP2763692(A2) |
申请公布日期 |
2014.08.13 |
申请号 |
EP20120775205 |
申请日期 |
2012.10.05 |
申请人 |
EUROPEAN MOLECULAR BIOLOGY LABORATORY |
发明人 |
BILBAO CORTES, DANIEL;LUCIANI, LUISA.;ROSENTHAL, NADIA |
分类号 |
A61K38/30;A61K48/00;A61P1/00;A61P3/10;A61P17/00;A61P25/28;C07K14/65 |
主分类号 |
A61K38/30 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|